You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FCN-011

Showing 1 - 25 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Shanghai (FCN-011)

Recruiting
  • Advanced Solid Tumor
  • FCN-011
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 16, 2021

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group

Not yet recruiting
  • Neurofibromatosis 1
  • +2 more
  • Test group (Group A): FCN-159 8 mg, orally, once daily;
  • Control group (Group B): Placebo, orally, once daily;
  • (no location specified)
Jun 16, 2023

Langerhans Cell Histiocytosis, LCH Trial (FCN-159)

Not yet recruiting
  • Langerhans Cell Histiocytosis
  • LCH
  • (no location specified)
Aug 15, 2023

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial in China, Spain, United States (FCN-159)

Recruiting
  • Neurofibromatosis 1
  • +2 more
  • Los Angeles, California
  • +11 more
Jul 25, 2022

Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • CB-011
  • New York, New York
  • +3 more
Feb 15, 2023

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Dec 7, 2022

Analgesia Trial in Bellaire, San Antonio (HTX-011, Bupivacaine Hydrochloride, Ibuprofen)

Completed
  • Analgesia
  • Bellaire, Texas
  • +1 more
Oct 25, 2023

Solid Tumor, Adult Trial in Orlando, Cincinnati (ADA-011, PD(L)-1 inhibitor)

Recruiting
  • Solid Tumor, Adult
  • Orlando, Florida
  • +1 more
Jan 6, 2023

Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia Trial in United States (HTX-011, Bupivacaine

Completed
  • Postoperative Pain
  • +2 more
  • Little Rock, Arkansas
  • +4 more
Oct 25, 2023

Solid Tumor, Adult Trial in Duarte, Nashville, San Antonio (FCN-437)

Completed
  • Solid Tumor, Adult
  • Duarte, California
  • +2 more
Mar 14, 2022

Non-muscle-invasive Bladder Cancer Trial in Myrtle Beach, Nashville (AU-011, AU-011 in Combination with Medical Laser)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • AU-011
  • AU-011 in Combination with Medical Laser
  • Myrtle Beach, South Carolina
  • +1 more
Jul 29, 2022

Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c,Fulvestrant,Goserelin acetate
  • Placebo,Fulvestrant,Goserelin acetate
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 30, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Primary Indeterminate Lesions or Choroidal Melanoma

Recruiting
  • Choroidal Melanoma
  • Indeterminate Lesions of Eye
    • Tucson, Arizona
    • +14 more
    Dec 7, 2022

    AU-011 or Plaque Radiotherapy for Primary Indeterminate Lesions

    Recruiting
    • Choroidal Melanoma
    • Indeterminate Lesions
    • Royal Oak, Michigan
    • +6 more
    Jun 16, 2022

    Hyperuricemia Trial in BeiJing (Placebo, fasted vs. high-fat meal)

    Recruiting
    • Hyperuricemia
    • Placebo
    • fasted vs. high-fat meal
    • BeiJing, Beijing, China
      Peking university Third Hospital
    Dec 20, 2021

    Advanced Breast Cancer, Female Breast Cancer Trial in Beijing (FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo,

    Recruiting
    • Advanced Breast Cancer
    • Female Breast Cancer
    • FCN-437c, Letrozole or anastrozole, Goserelin acetate
    • Placebo, Letrozole or anastrozole, Goserelin acetate
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Jul 4, 2022

    Beta Thalassemia Major, Beta Thalassemia Intermedia Trial in Worldwide (SOTATERCEPT (ACE-011))

    Completed
    • Beta Thalassemia Major
    • Beta Thalassemia Intermedia
    • SOTATERCEPT (ACE-011)
    • Créteil, France
    • +14 more
    Aug 18, 2022

    Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

    Active, not recruiting
    • Malignant Melanoma
    • Angiosarcoma
    • CICS-1 (investigational device),SPM-011(investigational drug)
    • Chuo Ku, Tokyo, Japan
      National Cancer Center Hospital
    Nov 6, 2022

    Solid Tumor Trial in Shanghai (FCN-098)

    Recruiting
    • Solid Tumor
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jan 16, 2022

    Myocardial Infarction Trial in Adelaide (NP-011 (Single Ascending Dose Phase), NP-011 (Multiple Ascending Dose Phase), NP-011

    Recruiting
    • Myocardial Infarction
    • NP-011 (Single Ascending Dose Phase)
    • +2 more
    • Adelaide, South Australia, Australia
      CMAX Clinical Research Pty Ltd
    Sep 26, 2022

    Advanced Solid Cancer Trial (ORB-011)

    Not yet recruiting
    • Advanced Solid Cancer
    • (no location specified)
    Jul 14, 2023

    Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

    Active, not recruiting
    • Multiple Myeloma
    • CT-011
    • Dendritic Cell Fusion Vaccine
    • Boston, Massachusetts
    • +2 more
    Sep 5, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Phoenix, Arizona
    • +137 more
    Jan 27, 2023